1. Patients hospitalized abroad as importers of multiresistant bacteria—a cross-sectional study 
T. Khawaja, J. Kirveskari, S. Johansson, J. Väisänen, A. Djupsjöbacka, A. Nevalainen, A. Kantele 
Clinical Microbiology and Infection 
Volume 23, Issue 9, Pages 673.e1-673.e8 (September 2017)
DOI: /j.cmi
Copyright © 2017 The Author(s) Terms and Conditions

2. Fig. 1
Prevalence of multidrug-resistant bacteria carriage in returning patients according to the geographic region of their prior hospitalization. Abbreviations: MDR, multidrug-resistant bacteria; MRSA, methicillin-resistant Staphylococcus aureus; ESPL-PE, extended-spectrum β-lactamase-producing Enterobacteriaceae; CPE, carbapenemase-producing Enterobacteriaceae.
Clinical Microbiology and Infection  , 673.e1-673.e8DOI: ( /j.cmi )
Copyright © 2017 The Author(s) Terms and Conditions

3. Fig. 2
Proportion of patients carrying multidrug-resistant bacteria by area visited and by use of antibiotics. Abbreviations and definitions: AB+, patients recorded as having received antibiotics either parenterally or orally while abroad; AB–, patients with no antibiotic use abroad; (Sub)tropics, Asia (excluding the former Soviet Union), Africa and Latin America; Temperate regions, Europe, North America and Oceania; MDR, multidrug-resistant bacteria; ESPL-PE, extended-spectrum β-lactamase-producing Enterobacteriaceae.
Clinical Microbiology and Infection  , 673.e1-673.e8DOI: ( /j.cmi )
Copyright © 2017 The Author(s) Terms and Conditions